Adding an artificial intelligence (AI) model to classify the emotional tone of patient communications can enhance support provided by an AI-chatbot to patients with breast cancer when tracking their ...
Therapeutic plasma exchange (TPE) may allow patients with advanced melanoma to overcome immune checkpoint inhibitor (ICI) resistance, according to research presented at the ESMO Congress 2025.
The usefulness of ChatGPT, a large language model, was investigated as a potential nurse decision-support tool for post-HSCT nursing care.
Telemedicine is emerging as an effective nursing intervention, especially through the use of mobile apps, for patients with breast cancer.
These data support the use of pembrolizumab plus weekly paclitaxel, with or without bevacizumab, as a new standard of care for patients with platinum-resistant, recurrent ovarian cancer,” said ...
Fruquintinib plus sintilimab showed superior clinical benefits over investigator’s choice of axilitinib or everolimus, with a tolerable safety profile, said Zhenhua Liu, MD.
An MCED blood test increased screenable cancer detection more than 7-fold when added to the US Preventive Services Task Force (USPSTF) A/B recommended screening.
Research presented at ESMO Congress 2025 demonstrates that adolescents and young adults are aware of skin cancer, but still do not consistently practice preventive behaviors.
The plan-act-study-do QI methodology was used to identify potential hazardous drug exposures and implement procedures to minimize those risks.
Emotional shock, cognitive overload, and the inherent complexity of AML present challenges for patients with AML at the time of diagnosis.
Adding osimertinib to platinum-based chemotherapy may improve outcomes in patients with EGFR-mutant, advanced NSCLC who had disease progression on first-line osimertinib.
The effectiveness of the Interaktor app was evaluated in a randomized trial of patients undergoing radiotherapy for prostate cancer monitor and manage their symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results